title: Bleeding associated with coadministration of rivaroxaban and clarithromycin.
authors.affiliation: Department of Medicine (Fralick, Juurlink, Marras), University of Toronto, Toronto, Ont.; Institute for Clinical Evaluative Sciences (Juurlink), Toronto, Ont.; Division of Internal Medicine (Juurlink), Sunnybrook Health Sciences Centre, Toronto, Ont.; Division of Respirology (Marras), Department of Medicine, University Health Network and Mount Sinai Hospital, Toronto, Ont. mike.fralick@mail.utoronto.ca.
authors.forename: Michael
authors.initials: M
authors.lastname: Fralick
authors.affiliation: Department of Medicine (Fralick, Juurlink, Marras), University of Toronto, Toronto, Ont.; Institute for Clinical Evaluative Sciences (Juurlink), Toronto, Ont.; Division of Internal Medicine (Juurlink), Sunnybrook Health Sciences Centre, Toronto, Ont.; Division of Respirology (Marras), Department of Medicine, University Health Network and Mount Sinai Hospital, Toronto, Ont.
authors.forename: David N
authors.initials: DN
authors.lastname: Juurlink
authors.affiliation: Department of Medicine (Fralick, Juurlink, Marras), University of Toronto, Toronto, Ont.; Institute for Clinical Evaluative Sciences (Juurlink), Toronto, Ont.; Division of Internal Medicine (Juurlink), Sunnybrook Health Sciences Centre, Toronto, Ont.; Division of Respirology (Marras), Department of Medicine, University Health Network and Mount Sinai Hospital, Toronto, Ont.
authors.forename: Theodore
authors.initials: T
authors.lastname: Marras
mesh_terms: D000368:Aged; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000009:adverse effects*; D017291:Clarithromycin / Q000008:administration & dosage / Q000009:adverse effects*; D004347:Drug Interactions; D065427:Factor Xa Inhibitors / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D020300:Intracranial Hemorrhages / Q000139:chemically induced* / Q000000981:diagnostic imaging / Q000628:therapy; D008297:Male; D000069552:Rivaroxaban / Q000008:administration & dosage / Q000009:adverse effects*; D014057:Tomography, X-Ray Computed
chemical_list: D000900:Anti-Bacterial Agents; D065427:Factor Xa Inhibitors; D000069552:Rivaroxaban; D017291:Clarithromycin
references.citation: Clin Pharmacol Ther. 1998 Jul;64(1):123-8
references.pmid: 9695727
references.citation: Arch Intern Med. 2005 May 23;165(10):1095-106
references.pmid: 15911722
references.citation: Emerg Med Int. 2014;2014:935474
references.pmid: 24696784
references.citation: Thromb J. 2013 Jul 03;11(1):11
references.pmid: 23822763
references.citation: N Engl J Med. 2015 Dec 17;373(25):2413-24
references.pmid: 26559317
references.citation: J Pharmacol Exp Ther. 2011 Jul;338(1):372-80
references.pmid: 21515813
references.citation: Am J Cardiol. 2013 Aug 1;112(3):454-60
references.pmid: 23642380
references.citation: Thromb Haemost. 2008 Jul;100(1):26-31
references.pmid: 18612534
references.citation: Thromb Haemost. 2012 Feb;107(2):379-87
references.pmid: 22187012
references.citation: Br J Clin Pharmacol. 2013 Sep;76(3):455-66
references.pmid: 23305158